AMPLIGEN
Ampligen is a biotechnology lab that specializes in genetic research and DNA testing.
AMPLIGEN
Industry:
Biotechnology Genetics Life Science
Founded:
1996-01-01
Address:
Ponferrada, Castilla Y Leon, Spain
Country:
Spain
Website Url:
http://www.ampligen.es
Total Employee:
11+
Status:
Active
Contact:
+34 987417110
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network Font Awesome
Similar Organizations
Aminoverse
Aminoverse is a biotech CRO that specializes in the research and development of enzymes.
Dispendix
Dispendix is a biotechnology company that specializes in single-cell printing.
e-Zyvec
E-Zyvec is a biotechnology company that specializes in genetic engineering.
Monaghan Biosciences
Monaghan Biosciences is a biotechnology company that specializes in the mushroom industry.
Nucelis
Nucelis is a biotechnology company that specializes in cell structure and function optimization.
Omixon
Omixon is a biotechnology company that specializes in high-resolution HLA genotyping.
Ten Bio
Ten Bio is a biotechnology company that provides ex vivo skin culture for research and lab testing.
Official Site Inspections
http://www.ampligen.es Semrush global rank: 319.09 K Semrush visits lastest month: 120.67 K
- Host name: 172.67.210.49
- IP address: 172.67.210.49
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Ampligen"
Ampligen - Crunchbase Company Profile & Funding
Ampligen is a biotechnology lab that specializes in genetic research and DNA testing. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... Contact Email [email protected]; Phone Number โฆSee details»
Ampligen: opiniones, equipo profesional, reconocimientos, โฆ
Ampligen: Contact Details and Business Profile - RocketReach
Ampligen: Laboratorio Genético en España Constituida en 1996, Ampligen es una empresa privada independiente dirigida por la Dra. Pilar Arca, especializada en la prestación de โฆSee details»
Ampligen Diagnósticos S.L. - Drug pipelines, Patents, Clinical trials ...
Explore Ampligen Diagnósticos S.L. with its drug pipeline, therapeutic area, technology platform, 16 news.See details»
Ampligen Diagnósticos - Products, Competitors, Financials, โฆ
Ampligen.es. Overview & Products; Founded Year ... and prenatal paternity testing, as well as DNA tests for familial relationships and genetic profiling. Ampligen also provides HPV โฆSee details»
Ampligen Diagnósticos S.L. - LinkedIn
Ampligen Diagnósticos S.L. | 144 followers on LinkedIn. Constituida en 1996, Ampligen es una empresa privada independiente dirigida por la Dra. Pilar Arca, especializada en la prestación โฆSee details»
Ampligen Diagnósticos Overview | SignalHire Company Profile
Ampligen: Laboratorio Genético en España Constituida en 1996, Ampligen es una empresa privada independiente dirigida por la Dra. Pilar Arca, especializada en la prestación de โฆSee details»
AMPLIGEN DIAGNOSTICOS SOCIEDAD LIMITADA. Company โฆ
Find company research, competitor information, contact details & financial data for AMPLIGEN DIAGNOSTICOS SOCIEDAD LIMITADA. of PONFERRADA. Get the latest business insights โฆSee details»
Ampligen | VentureRadar
Ampligen is a laboratory specialised in diagnostic testing for human papillomavirus (HPV), paternity testing, and any other types of DNA testing. ... Find out more about Ampligen โฆSee details»
Ampligen - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 Ampligen is a biotechnology lab that specializes in genetic research and DNA testing.See details»
Ampligen Biotecnologia LTDA - Overview, News & Similar
Ampligen Biotecnologia LTDA is a company that operates in the Biotechnology industry. It employs 51-100 people and has $1M-$5M of revenue. The comp any is headquartered in โฆSee details»
Ampligen โ the first drug approved in the world for ME/CFS
Aug 26, 2016 Ampligen was approved for use in people with โsevere ME/CFSโ โ a designation that was based on the type of ME/CFS patients that took part in the companyโs original U.S. โฆSee details»
Rintatolimod - Wikipedia
Rintatolimod, sold under the tradename Ampligen, is a medication intended for treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). [1] There is some evidence it โฆSee details»
Marketing History of Ampligen - MEpedia
Marketing history [edit | edit source]. Since early in Ampligen's development, AIM ImmunoTech has entered into many agreements with different distribution companies around the world โฆSee details»
Ampligen - MEpedia
Rintatolimod (tradename Ampligen®) is a mismatched, double-stranded RNA molecule with immunomodulatory and antiviral properties. The drug acts as a TLR3 agonist which stimulates โฆSee details»
Ampligen Takes Big Step Forward - Health Rising
Aug 26, 2016 Ampligen was approved for use in people with "severe ME/CFS" - a designation that was based on the type of ME/CFS patients that took part in the company's original U.S. โฆSee details»
Ampligen Takes Big Step Forward - Health Rising
Aug 26, 2016 Ampligen became the first drug ever approved for use in ME/CFS when ANMAT, Argentineโs FDA, approved the drug for use in severe ME/CFS patients. The approval should โฆSee details»
Ampligen: A General Overview and the Plan for
โข Ampligen is the only TLR3 agonist to avoid helicase activation of NF-ฮบB. Natural dsRNAs and poly IC which activate NF-ฮบB in the tumor microenvironment (TME) โTregs and have the โฆSee details»
Ampligen Chronic Fatigue Syndrome (ME/CFS) Resource Center
The Ampligen Chronicles โ in entertaining, at times side-splitting fashion, Kelvin Lord tracks his progress on Ampligen from a highly disabled person with chronic fatigue syndrome toโฆ.. Dr. โฆSee details»
Ampligen โ American ME and CFS Society - ammes.org
Ampligen® is the only drug to have completed a Phase 3 clinical trial in the U.S. in ME/CFS. Earlier this year Hemispherx began supplying Ampligen® for pancreatic cancer patients in an โฆSee details»